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Abstract
Background: There is a lack of knowledge regarding the frequency of disease associated polymorphisms in 
populations and population attributable risk for many populations remains unknown. Factors that could affect the 
association of the allele with disease, either positively or negatively, such as race, ethnicity, and gender, may not be 
possible to determine without population based allele frequencies.
Here we used a panel of 51 polymorphisms previously associated with at least one disease and determined the allele 
frequencies within the entire Personalized Medicine Research Project population based cohort. We compared these 
allele frequencies to those in dbSNP and other data sources stratified by race. Differences in allele frequencies between 
self reported race, region of origin, and sex were determined.
Results: There were 19544 individuals who self reported a single racial category, 19027 or (97.4%) self reported white 
Caucasian, and 11205 (57.3%) individuals were female. Of the 11,208 (57%) individuals with an identifiable region of 
origin 8337 or (74.4%) were German.
41 polymorphisms were significantly different between self reported race at the 0.05 level. Stratification of our 
Caucasian population by self reported region of origin revealed 19 polymorphisms that were significantly different (p = 
0.05) between individuals of different origins. Further stratification of the population by gender revealed few significant 
differences in allele frequencies between the genders.
Conclusions: This represents one of the largest population based allele frequency studies to date. Stratification by self 
reported race and region of origin revealed wide differences in allele frequencies not only by race but also by region of 
origin within a single racial group. We report allele frequencies for our Asian/Hmong and American Indian populations; 
these two minority groups are not typically selected for population allele frequency detection. Population wide allele 
frequencies are important for the design and implementation of studies and for determining the relevance of a disease 
associated polymorphism for a given population.
Background
One of the challenges for translating disease associated
polymorphisms into use is the lack of knowledge regard-
ing the frequency of the polymorphism in the targeted
population. Without this information, population attrib-
utable risk remains unknown. In addition, factors that
could affect the association of the allele with disease,
either positively or negatively, such as ethnicity and gen-
der, may not be possible to determine without population
based allele frequencies. There are a number of reasons
that these frequencies have yet to be determined. Disease
associations whether completed through candidate gene
studies or genome wide studies are determined using case
control studies that classify affected and unaffected indi-
viduals but are not necessarily representative of a popula-
tion and may need correction for population
stratification [1-5]. Another reason that many polymor-
phisms lack population allele frequencies is cost; without
a clear necessity to genotype a large diverse population
funding for such studies is scarce [6,7]. Finally, with the
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creation of large population wide biorepositories still in
its infancy there has been a lack of samples for genotyp-
ing [8-11].
In the past, geneticists have relied on a small popula-
tion of well characterized reference samples to estimate
allele frequency in a population [12-15]. These samples
include the HapMap collection of individuals with differ-
ent ethnicities that has been anonomized and immortal-
ized by Coriell [13,14]. These populations form the
population allele frequencies most often used in dbSNP
[15] and a subset of these samples are also used for popu-
lation allele frequencies on the Cancer500 website [12].
While these population samples are a valuable resource,
they were not collected to be representative of a popula-
tion and are often made up of related individuals. Even
with the advent of the 1000 genomes project [16], there
will still be a relatively few samples of any ethnic back-
ground to determine population allele frequencies with
any certainty. This lack of a representative population dis-
tribution may not lead to representative population allele
frequencies [2,3,5,8,1]. Ethnicities, such as Hispanic, are
not well represented within the dbSNP database with
often less than 100 individuals genotyped to determine
population allele frequencies. Other backgrounds such as
Native American may be missing from dbSNP all
together [15].
One of the most widely used population samples the
Centre d'Etude du Polymorphisme Humain (CEPH)
Human Diversity Panel, has been successful for deter-
mining large trends in human diversity and population
structure [17-21], however even with the Caucasian pop-
ulation available from this Centre d'Etude du Polymor-
phisme Humain (CEPH) collection and other collections,
there are too few individuals to determine allelic variation
within an ethnic population. Recent studies have shown
that even within the Central European population the
country of origin can have a great impact on allele fre-
quencies with clearly seen variation between countries
and even within a country [22-24][Feder, 2008 #87;Han-
nelius, 2008 #107]. This creates an even more challenging
problem when attempting to use these generalized allele
frequencies in a given population to estimate the burden
disease associated polymorphisms have on disease within
a population [20,21]. Current genome wide association
studies (GWAS) control for this by stratifying the individ-
uals by ethnicity and country of origin but because of
their case-control nature these studies are less informa-
tive regarding allele frequencies for an entire population
group [2,3,5,8,1].
One method of determining population wide allele fre-
quencies is to genotype entire biorepositories regardless
of case or control status. There are several repositories
that are population based, including NHANES III [25],
the UK biobank [11], the Marshfield Clinic Research
Foundation Personalized Medicine Research Project [26],
the Kaiser Permanente Research Program on Genes Envi-
ronment and Health [8], and the Vanderbilt Databank
Resource [10]. These biorepositories offer a broad cross
sectional population available for genotyping and will be
a valuable resource as more genotypes become publically
available from all of these resources.
H e r e  w e  u s e d  a  p a n e l  o f  p o l y m o r p h i s m s  p r e v i o u s l y
associated with disease and used as quality control mark-
ers in the PMRP population [27] to determine the allele
frequencies within the entire Personalized Medicine
Research Project population based cohort (Additional
File 1). These allele frequencies found in our population
were then compared to the frequencies found in dbSNP
and other data bases stratified by race, with some of these
allele frequencies varying over 10% from the reported
allele frequencies. Differences in allele frequencies
between self reported ethnicities within our population
and differences between sexes were determined as well.
Results
Population Characteristics
Demographic characteristics for the population are pre-
sented in Table 1. There were 19544 individuals who self
reported a single racial category, of these individuals the
vast majority (19027 or 97.4%) self reported white Cauca-
sian. Of individuals who selected ancestral origin, 11,208
(57%) selected either a single ancestral origin or two
ancestral origins that were grouped together for our anal-
ysis (ex. Norwegian and Swedish). Of the individuals in
the analysis the majority self reported German origin
(8337 or 74.4%). Females outnumbered males in our sam-
ple with 11205 (57.3%) individuals with confirmed female
sex.
Population allele frequencies
As expected our population allele frequencies were sig-
nificantly different for different self reported races. Allele
frequencies stratified by race are reported in Table 2. Of
the 51 polymorphisms tested 41 were significantly differ-
ent between self reported race at the 0.05 level with 35
polymorphisms significantly different with p values of <
0.0001 (Table 2). Of these polymorphisms, 13 exhibited a
minor allele frequency of over 50% within a racial cate-
gory although the limited size of the non-Caucasian
groups in this study creates a large amount of uncertainty
regarding the actual allele frequencies in these racially
stratified populations (Figure 1). For alleles with greater
than a 2% minor allele frequency, only two polymor-
phisms deviated from Hardy Weinberg equilibrium (p =
0.01), rs4680 in the COMT gene in Black/African Ameri-
can individuals and rs1800588 in the LIPC gene in indi-
viduals self reported as Hispanic.Cross et al. BMC Genetics 2010, 11:51
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We compared the allele frequencies of our population
with two previously published population allele frequen-
cies, the CLUE II population [28] and the NHANES III
population [29] as well as comparing our allele frequen-
cies to those of dbSNP [15]and Cancer500 [28] allele fre-
quencies. There were three polymorphisms assayed in all
four populations, and when compared, our allele frequen-
cies varied little from previously published population
allele frequencies (Figure 2). Our Caucasian allele fre-
quencies were within 2% of the NHANES III [29] and
CLUE II [28] allele frequencies and our African American
and Hispanic allele frequencies we were within 5% of
these previously reported populations. In contrast, the
allele frequencies reported here showed more variability
when compared to reported allele frequencies in dbSNP
[15]. When we compared all of the allele frequencies with
those reported in the dbSNP [15] and Cancer500 [12]
websites several polymorphisms differed by more than
10%. (Additional File 2). Unfortunately our American
Indian population could not be compared as this is not
one of the populations with widely reported allele fre-
quencies.
Allele frequencies by self reported region of ancestry
There is mounting evidence that further population strat-
ifications may be necessary as even within a racial group
there can be significant differences among people of dif-
ferent ancestral origin. To investigate this, we stratified
our Caucasian population by self reported region of ori-
gin to determine if there were differences in allele fre-
quencies between individuals. 11,205 (57%) individuals
could be categorized by a region of origin. Using this pop-
ulation, there were 19 polymorphisms that were signifi-
cantly different (p = 0.05) between individuals of different
origins (Table 3). Of these 5 (rs231775, rs6280, rs351855,
rs601338, and rs429358) were significantly different with
a p value of 0.0001 or less. Interestingly, the allele fre-
quencies of some of the ethnic groups fell outside the 95%
confidence interval of the total Caucasian MAF particu-
larly the Eastern European ethnicity (Figure 3, Table 3).
Allele frequencies by gender
Further stratification of the population by gender
revealed few significant differences in allele frequencies
between the genders. Only three polymorphisms were
different in the total population p < 0.05 rs7121 (GNAS),
rs1801253 (ADRB1) and rs1042714 (ADRB2). After strat-
ification by racial group, these three polymorphisms were
associated with gender differences in the white racial
group. Three different polymorphisms exhibited gender
differences in black individuals. Hispanic genders were
different in two polymorphisms. Among the American
Indian population 5 polymorphisms were different
between genders and the Asian/Hmong population
exhibited the greatest number of polymorphisms with
gender differences with 7 polymorphisms. (Additional
File 3).
Table 1: Population demographics for individuals genotyped within the PMRP cohort
Self Reported Race/Ethnicity/Region of Ancestry Number of participants Sex
Male Female
Self Reported 19544 8338 11206 (57.3%)
Race/Ethnicity
White/Caucasian 19027 (97.35%) 8095 10932
White/Hispanic 206 (1.05%) 98 108
Black/African American 50 (0.26%) 31 19
Asian/Hmong 94 (0.48%) 36 58
American Indian 167 (0.85%) 69 98
Self Reported Region of Ancestry 11208
Germany 8337 (74.38%) 3741 4596
Eastern Europe (Poland/Czech Republic) 780 (6.96%) 357 423
Scandinavia (Sweden/Norway) 653 (5.83%) 306 347
British and Irish Isles 1438 (12.83%) 638 800C
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Table 2: Population allele frequencies stratified by self reported race
Gene Polymorphism Allele
(MA)
Population
MAF
(95% CI)
White/
Caucasian
MAF
(95% CI)
White
Hispanic
MAF
(95% CI)
Black
African American
MAF
(95% CI)
Asian
Hmong
MAF
(95% CI)
American
Indian
MAF
(95% CI)
P value
LEPR rs1137101 G(A) 0.459
(0.454-0.464)
0.544
(0.539-0.549)
0.493
(0.445-0.541)
0.410
(0.314-0.506)
0.330
(0.263-0.397)
0.479
(0.425-0.533)
<0.0001
RNASEL rs486907 G(A) 0.375
(0.370-0.380)
0.379
(0.374-0.384)
0.214
(0.174-0.254)
0.100
(0.041-0.159)
0.308
(0.242-0.374)
0.284
(0.236-0.332)
<0.0001
APOB rs1042031 G(A) 0.180
(0.176-0.184)
0.18
(0.176-0.184)
0.167
(0.131-0.203)
0.220
(0.139-0.301)
0.063
(0.028-0.098)
0.182
(0.141-0.223)
0.0023
CTLA4 rs231775 A(G) 0.388
(0.383-0.393)
0.386
(0.381-0.391)
0.480
(0.432-0.528)
0.370
(0.275-0.465)
0.479
(0.408-0.550)
0.413
(0.360-0.466)
<0.0001
AGTR1 rs5186 A(C) 0.298
(0.293-0.303)
0.299
(0.294-0.304)
0.306
(0.262-0.350)
0.110
(0.049-0.171)
0.106
(0.062-0.150)
0.287
(0.238-0.336)
<0.0001
DRD3 rs6280 T(C) 0.315
(0.310-0.320)
0.311
(0.306-0.316)
0.480
(0.432-0.528)
0.240
(0.156-0.324)
0.297
(0.232-0.362)
0.359
(0.308-0.410)
<0.0001
FABP2 rs1799883 G(A) 0.262
(0.258-0.266)
0.261
(0.257-0.265)
0.293
(0.249-0.337)
0.240
(0.156-0.324)
0.250
(0.188-0.312)
0.295
(0.246-0.344)
0.3968
ADD1 rs4961 G(T) 0.192
(0.188-0.196)
0.191
(0.187-0.195)
0.209
(0.170-0.248)
0.100
(0.041-0.159)
0.346
(0.278-0.414)
0.165
(0.125-0.205)
<0.0001
ADRB2 rs1042714 C(G) 0.428
(0.423-0.433)
0.433
(0.428-0.438)
0.214
(0.174-0.254)
0.250
(0.165-0.335)
0.170
(0.116-0.224)
0.404
(0.351-0.457)
<0.0001
FGFR4 rs351855 C(T) 0.305
(0.300-0.310)
0.303
(0.298-0.308)
0.430
(0.382-0.478)
0.170
(0.096-0.244)
0.436
(0.365-0.507)
0.314
(0.264-0.364)
<0.0001
EDN1 rs5370 G(T) 0.213
(0.209-0.217)
0.214
(0.210-0.218)
0.182
(0.145-0.219)
0.180
(0.105-0.255)
0.255
(0.193-0.317)
0.165
(0.125-0.205)
0.0835
HTR1B rs6296 G(C) 0.270
(0.266-0.274)
0.268
(0.264 -0.272)
0.391
(0.344-0.438)
0.220
(0.139-0.301)
0.367
(0.298-0.436)
0.320
(0.270-0.370)
<0.0001
EGFR rs2227983 G(A) 0.255
(0.251-0.259)
0.253
(0.249-0.257)
0.313
(0.268-0.358)
0.090
(0.034-0.146)
0.527
(0.456-0.598)
0.275
(0.227-0.323)
<0.0001
CFTR rs213950 G(A) 0.428
(0.423-0.433)
0.426
(0.421-0.431)
0.512
(0.464-0.560)
0.760
(0.676-0.844)
0.484
(0.413-0.555)
0.389
(0.337-0.441)
<0.0001
PON2 rs7493 C(G) 0.244
(0.240-0.248)
0.244
(0.240-0.248)
0.231
(0.190-0.272)
0.350
(0.257-0.443)
0.245
(0.184-0.306)
0.207
(0.164-0.250)
0.2519
LPL rs328 C(G) 0.098
(0.095-0.101)
0.098
(0.095-0.101)
0.083
(0.056-0.110)
0.080
(0.027-0.133)
0.080
(0.041-0.119)
0.108
(0.075-0.141)
0.9200C
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9p21 rs2383206 A(G) 0.500
(0.495-0.505)
0.499
(0.494-0.504)
0.551
(0.503-0.599)
0.550
(0.452-0.648)
0.505
(0.434-0.576)
0.547
(0.494-0.600)
0.2803
RET rs1800861 A(C) 0.233
(0.229-0.237)
0.232
(0.228-0.236)
0.218
(0.178-0.258)
0.130
(0.064-0.196)
0.452
(0.381-0.523)
0.219
(0.175-0.263)
<0.0001
ADRB1 rs1801253 C(G) 0.270
(0.266-0.274)
0.271
(0.267-0.275)
0.163
(0.127-0.199)
0.500
(0.402-0.598)
0.229
(0.169-0.289)
0.222
(0.177-0.267)
<0.0001
PLAU rs2227564 C(T) 0.247
(0.243-0.251)
0.247
(0.243-0.251)
0.250
(0.208-0.292)
0.100
(0.041-0.159)
0.299
(0.234-0.364)
0.246
(0.200-0.292)
0.354
MMP1 rs1799750 -(G) 0.471
(0.466-0.476)
0.469
(0.464-0.474)
0.638
(0.592-0.684)
0.460
(0.362-0.558)
0.565
(0.494-0.636)
0.494
(0.440-0.548)
<0.0001
VWF rs1063856 A(G) 0.359
(0.354-0.364)
0.361
(0.356-0.366)
0.250
(0.208-0.292)
0.490
(0.392-0.588)
0.170
(0.116-0.224)
0.290
(0.241-0.339)
<0.0001
HTR2A rs6313 C(T) 0.406
(0.401-0.411)
0.406
(0.401-0.411)
0.369
(0.322-0.416)
0.350
(0.257-0.443)
0.450
(0.379-0.521)
0.392
(0.340-0.444)
0.3286
MTHFD1 rs2236225 C(T) 0.448
(0.443-0.453)
0.447
(0.442-0.452)
0.578
(0.530-0.626)
0.240
(0.156-0.324)
0.293
(0.228-0.358)
0.476
(0.422-0.530)
<0.0001
LIPC rs1800588 C(T) 0.218
(0.214-0.222)
0.214
(0.210-0.218)
0.480
(0.432-0.528)
0.430
(0.333-0.527)
0.346
(0.278-0.414)
0.254
(0.207-0.301)
<0.0001
MMP2 rs243865 C(T) 0.246
(0.242-0.250)
0.247
(0.243-0.251)
0.218
(0.178-0.258)
0.100
(0.041-0.159)
0.112
(0.067-0.157)
0.257
(0.210-0.304)
<0.0001
CYBA rs4673 C(T) 0.339
(0.334-0.344)
0.341
(0.336-0.346)
0.209
(0.170-0.248)
0.370
(0.275-0.465)
0.213
(0.154-0.272)
0.371
(0.319-0.423)
<0.0001
CETP rs708272 C(T) 0.421
(0.416-0.426)
0.422
(0.417-0.427)
0.432
(0.384-0.480)
0.306
(0.216-0.396)
0.398
(0.328-0.468)
0.428
(0.375-0.481)
0.0924
ELAC2 rs4792311 G(A) 0.303
(0.298-0.308)
0.304
(0.299-0.309)
0.262
(0.220-0.304)
0.280
(0.192-0.368)
0.165
(0.112-0.218)
0.317
(0.267-0.367)
<0.0001
ENOSF1/TYMS rs16430 +(-) 0.299
(0.294-0.304)
0.297
(0.292-0.302)
0.347
(0.301-0.393)
0.470
(0.372-0.568)
0.585
(0.515-0.655)
0.293
(0.244-0.342)
<0.0001
FUT2 rs601338 G(A) 0.456
(0.451-0.461)
0.267
(0.224-0.310)
0.500
(0.402-0.598)
0.133
(0.084-0.182)
0.410
(0.357-0.463)
<0.0001
LDLR rs688 C(T) 0.422
(0.417-0.427)
0.423
(0.418-0.428)
0.425
(0.377-0.473)
0.150
(0.080-0.220)
0.335
(0.268-0.402)
0.467
(0.413-0.521)
<0.0001
GNAS rs7121 C(T) 0.480
(0.475-0.485)
0.477
(0.472-0.482)
0.575
(0.527-0.623)
0.700
(0.610-0.790)
0.606
(0.536-0.676)
0.545
(0.492-0.598)
<0.0001
CBS rs234706 G(A) 0.345
(0.340-0.350)
0.348
(0.343-0.353)
0.233
(0.192-0.274)
0.220
(0.139-0.301)
0.118
(0.072-0.164)
0.335
(0.284-0.386)
<0.0001
IL1B rs16944 G(A) 0.334
(0.329-0.339)
0.329
(0.324-0.334)
0.566
(0.518-0.614)
0.550
(0.452-0.648)
0.500
(0.429-0.571)
0.437
(0.384-0.490)
<0.0001
Table 2: Population allele frequencies stratified by self reported race (Continued)C
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NOS3 rs1799983 G(T) 0.306
(0.301-0.311)
0.308
(0.303-0.313)
0.228
(0.187-0.269)
0.130
(0.064-0.196)
0.149
(0.098-0.200)
0.263
(0.216-0.310)
<0.0001
TGFB1 rs1800469 C(T) 0.308
(0.303-0.313)
0.306
(0.301-0.311)
0.468
(0.420-0.516)
0.250
(0.165-0.335)
0.410
(0.340-0.480)
0.287
(0.238-0.336)
<0.0001
TNFa rs1800629 G(A) 0.170
(0.166-0.174)
0.171
(0.167-0.175)
0.083
(0.056-0.110)
0.160
(0.088-0.232)
0.080
(0.041-0.119)
0.132
(0.096-0.168)
<0.0001
IL6 rs1800795 G(C) 0.434
(0.429-0.439)
0.440
(0.435-0.445)
0.199
(0.160-0.238)
0.160
(0.088-0.232)
0.085
(0.045-0.125)
0.326
(0.276-0.376)
<0.0001
IL6 rs1800796 G(C) 0.057
(0.055-0.059)
0.052
(0.050-0.054)
0.260
(0.218-0.302)
0.110
(0.049-0.171)
0.479
(0.408-0.550)
0.111
(0.077-0.145)
<0.0001
IL10 rs1800872 C(A) 0.244
(0.240-0.248)
0.240
(0.236-0.244)
0.362
(0.316-0.408)
0.350
(0.257-0.443)
0.553
(0.482-0.624)
0.269
(0.221-0.317)
<0.0001
MTHFR rs1801133 C(T) 0.327
(0.322-0.332)
0.327
(0.322-0.332)
0.485
(0.437-0.533)
0.100
(0.041-0.159)
0.229
(0.169-0.289)
0.344
(0.293-0.395)
<0.0001
LPL rs268 A(G) 0.020
(0.019-0.021)
0.020
(0.019-0.021)
0.001
(0.000-0.004)
0 0 0.015
(0.002-0.028)
NA
ACE rs4291 A(T) 0.377
(0.372-0.382)
0.389
(0.384-0.394)
0.415
(0.367-0.463)
0.347
(0.254-0.440)
0.316
(0.250-0.382)
0.377
(0.325-0.429)
0.2086
ACE rs4343 G(A) 0.481
(0.476-0.486)
0.479
(0.474-0.484)
0.556
(0.508-0.604)
0.710
(0.621-0.799)
0.580
(0.509-0.651)
0.488
(0.434-0.542)
<0.0001
APOE rs429358 T(C) 0.144
(0.141-0.147)
0.145
(0.141-0.149)
0.100
(0.071-0.129)
0.220
(0.139-0.301)
0.085
(0.045-0.125)
0.123
(0.088-0.158)
0.0108
APOE rs7412 C(T) 0.083
(0.080-0.086)
0.083
(0.080-0.086)
0.030
(0.014-0.046)
0.140
(0.072-0.208)
0.060
(0.026-0.094)
0.084
(0.054-0.114)
0.0056
COMT rs4680 A(G) 0.469
(0.464-0.474)
0.466
(0.461-0.471)
0.570
(0.522-0.618)
0.690
(0.599-0.781)
0.654
(0.586-0.722)
0.461
(0.408-0.514)
<0.0001
VDR rs7975232 A(C) 0.485
(0.480-0.490)
0.483
(0.478-0.488)
0.573
(0.525-0.621)
0.410
(0.314-0.506)
0.633
(0.564-0.702)
0.500
(0.446-0.554)
<0.0001
VDR rs731236 T(C) 0.384
(0.379-0.389)
0.387
(0.382-0.392)
0.245
(0.203-0.287)
0.320
(0.229-0.411)
0.165
(0.112-0.218)
0.359
(0.308-0.410)
<0.0001
VDR rs1544410 G(A) 0.389
(0.384-0.394)
0.392
(0.387-0.397)
0.243
(0.202-0.284)
0.310
(0.219-0.401)
0.223
(0.163-0.283)
0.344
(0.293-0.395)
<0.0001
Table 2: Population allele frequencies stratified by self reported race (Continued)Cross et al. BMC Genetics 2010, 11:51
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Discussion
This study determined the allele frequencies of 51 poly-
morphisms, previously associated with at least one dis-
ease state, in a large rural population. This represents one
of the largest population based allele frequency studies to
date. Stratification by self reported race and region of ori-
gin revealed wide differences in allele frequencies not
only by race but also by region of origin within a single
racial gr oup. Her e we report alle le fr equencies for our
Asian/Hmong and American Indian populations. These
two minority groups are not typically selected for popula-
tion allele frequency detection. Stratification of our Cau-
casian population by region of origin revealed
significantly different allele frequencies within a single
racial group. As we move from gene disease discovery to
the application of genetic knowledge, the true population
wide allele frequencies become more important for the
design and implementation of studies and for determin-
ing the relevance of a disease associated polymorphism
for a given population.
Several recent studies have reported population wide
allele frequencies; our study complements these previ-
ously published studies and contributes new information.
The two largest US population allele frequency studies
NHANES III [29]and CLUE II [28] also chose to report
allele frequencies for polymorphisms associated with dis-
ease. The NHANES III study published allele frequencies
from a nationally representative cohort for 91 polymor-
phisms previously associated with disease [29]; our study
included 7 of these polymorphisms. The CLUE II popula-
tion was genotyped for 49 polymorphisms in inflamma-
tory genes [28], of which we also report allele frequencies
for 4 of these polymorphisms. We chose to compare allele
frequencies for the 3 polymorphisms all studies had in
common. Our reported allele frequencies were very simi-
lar with 2 polymorphisms varying less than 1% between
the studies, particularly when comparing the Caucasian
popula tion. T his similarity in allele frequencies is con-
trasted with the dbSNP allele frequencies [15] which we
varied from by over 10% for a number of polymorphisms.
This highlights the continued need for large population
based genotyping efforts to determine allele frequencies
of disease associated polymorphisms.
Beyond agreeing with previously published population
allele frequencies, this study reports allele frequencies for
43 polymorphisms not genotyped in either the NHANES
III [29] or CLUE II populations [28]. The additional poly-
morphisms included alleles that have been associated
with a number of different diseases such as cancer, heart
disease, and diabetes [27] and will contribute to our
understanding of disease risk. We also report initial pop-
ulation allele frequencies for two additional minority
groups that have importance for our population; the
Asian/Hmong and American Indian populations. How-
ever our minority allele frequencies have a high degree of
uncertainty given the small number of individuals within
Figure 1 Polymorphisms with major and minor alleles that vary with race. Minor allele frequency for the total population and the same allele for 
each racial group, with 95% confidence intervals.
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Figure 2 Minor allele frequencies of 3 polymorphisms tested in different National populations stratified by race. Comparison populations 
include NHANES III, CLUE II, PMRP, and dbSNP. A. Caucasian population B. African American Population C. Hispanic Population. Minor allele frequencies 
include 95% confidence intervals for the population minor allele frequency.
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Table 3: Population Caucasian allele frequencies stratified by self reported region of ancestry
Gene Polymorphism Allele
(MA)
White
Caucasian
MAF
(95% CI)
British and Irish Isles
MAF
(95% CI)
Eastern Europe
MAF
(95% CI)
Germany
MAF
(95% CI)
Scandinavia
MAF
(95% CI)
P value
LEPR rs1137101 G(A) 0.544
(0.539-0.549)
0.554
(0.536-0.572)
0.523
(0.498-0.548)
0.544
(0.536-0.552)
0.500
(0.473-0.527)
0.032
RNASEL rs486907 G(A) 0.379
(0.374-0.384)
0.363
(0.345-0.381)
0.381
(0.357-0.405)
0.384
(0.377-0.391)
0.376
(0.350-0.402)
0.553
APOB rs1042031 G(A) 0.18
(0.176-0.184)
0.190
(0.176-0.204)
0.179
(0.160-0.198)
0.184
(0.178-0.190)
0.153
(0.133-0.173)
0.143
CTLA4 rs231775 A(G) 0.386
(0.381-0.391)
0.394
(0.376-0.412)
0.422
(0.397-0.447)
0.373
(0.366-0.380)
0.422
(0.395-0.449)
<0.0001
AGTR1 rs5186 A(C) 0.299
(0.294-0.304)
0.298
(0.281-0.315)
0.285
(0.263-0.307)
0.305
(0.298-0.312)
0.278
(0.254-0.302)
0.185
DRD3 rs6280 T(C) 0.311
(0.306-0.316)
0.342
(0.325-0.359)
0.270
(0.248-0.292)
0.316
(0.309-0.323)
0.306
(0.281-0.331)
0.0001
FABP2 rs1799883 G(A) 0.261
(0.257-0.265)
0.261
(0.245-0.277)
0.258
(0.236-0.280)
0.261
(0.254-0.268)
0.271
(0.247-0.295)
0.871
ADD1 rs4961 G(T) 0.191
(0.187-0.195)
0.188
(0.174-0.202)
0.165
(0.147-0.183)
0.192
(0.186-0.198)
0.197
(0.175-0.219)
0.158
ADRB2 rs1042714 C(G) 0.433
(0.428-0.438)
0.457
(0.439-0.475)
0.403
(0.379-0.427)
0.428
(0.420-0.436)
0.419
(0.392-0.446)
0.0018
FGFR4 rs351855 C(T) 0.303
(0.298-0.308)
0.286
(0.269-0.303)
0.351
(0.327-0.375)
0.299
(0.292-0.306)
0.330
(0.304-0.356)
<0.0001
EDN1 rs5370 G(T) 0.214
(0.210-0.218)
0.218
(0.203-0.233)
0.193
(0.173-0.213)
0.210
(0.204-0.216)
0.201
(0.179-0.223)
0.524
HTR1B rs6296 G(C) 0.268
(0.264-0.272)
0.266
(0.250-0.282)
0.281
(0.259-0.303)
0.264
(0.257-0.271)
0.290
(0.265-0.315)
0.045
EGFR rs2227983 G(A) 0.253
(0.249-0.257)
0.265
(0.249-0.281)
0.260
(0.238-0.282)
0.250
(0.243-0.257)
0.260
(0.236-0.284)
0.209
CFTR rs213950 G(A) 0.426
(0.421-0.431)
0.423
(0.405-0.441)
0.444
(0.419-0.469)
0.427
(0.419-0.435)
0.424
(0.397-0.451)
0.085
PON2 rs7493 C(G) 0.244
(0.240-0.248)
0.252
(0.236-0.268)
0.279
(0.257-0.301)
0.239
(0.233-0.245)
0.257
(0.233-0.281)
0.004
LPL rs328 C(G) 0.098
(0.095-0.101)
0.099
(0.088-0.110)
0.092
(0.078-0.106)
0.099
(0.094-0.104)
0.090
(0.074-0.106)
0.682C
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9p21 rs2383206 A(G) 0.499
(0.494-0.504)
0.522
(0.504-0.540)
0.496
(0.471-0.521)
0.495
(0.487-0.503)
0.477
(0.450-0.504)
0.150
RET rs1800861 A(C) 0.232
(0.228-0.236)
0.213
(0.198-0.228)
0.256
(0.234-0.278)
0.240
(0.234-0.246)
0.203
(0.181-0.225)
0.001
ADRB1 rs1801253 C(G) 0.271
(0.267-0.275)
0.264
(0.248-0.280)
0.269
(0.247-0.291)
0.270
(0.263-0.277)
0.275
(0.251-0.299)
0.922
PLAU rs2227564 C(T) 0.247
(0.243-0.251)
0.239
(0.223-0.255)
0.219
(0.198-0.240)
0.244
(0.237-0.251)
0.277
(0.253-0.301)
0.012
MMP1 rs1799750 -(G) 0.469
(0.464-0.474)
0.486
(0.468-0.504)
0.458
(0.433-0.483)
0.460
(0.452-0.468)
0.505
(0.478-0.532)
0.020
VWF rs1063856 A(G) 0.361
(0.356-0.366)
0.381
(0.363-0.399)
0.337
(0.314-0.360)
0.353
(0.346-0.360)
0.372
(0.346-0.398)
0.006
HTR2A rs6313 C(T) 0.406
(0.401-0.411)
0.400
(0.382-0.418)
0.370
(0.346-0.394)
0.412
(0.405-0.419)
0.397
(0.370-0.424)
0.071
MTHFD1 rs2236225 C(T) 0.447
(0.442-0.452)
0.456
(0.438-0.474)
0.442
(0.417-0.467)
0.446
(0.438-0.454)
0.439
(0.412-0.466)
0.792
LIPC rs1800588 C(T) 0.214
(0.210-0.218)
0.225
(0.210-0.240)
0.232
(0.211-0.253)
0.213
(0.207-0.219)
0.212
(0.190-0.234)
0.077
MMP2 rs243865 C(T) 0.247
(0.243-0.251)
0.242
(0.226-0.258)
0.257
(0.235-0.279)
0.243
(0.236-0.250)
0.248
(0.225-0.271)
0.888
CYBA rs4673 C(T) 0.341
(0.336-0.346)
0.318
(0.301-0.335)
0.365
(0.341-0.389)
0.338
(0.331-0.345)
0.325
(0.300-0.350)
0.083
CETP rs708272 C(T) 0.422
(0.417-0.427)
0.436
(0.418-0.454)
0.409
(0.385-0.433)
0.420
(0.413-0.427)
0.436
(0.409-0.463)
0.027
ELAC2 rs4792311 G(A) 0.304
(0.299-0.309)
0.291
(0.274-0.308)
0.304
(0.281-0.327)
0.309
(0.302-0.316)
0.292
(0.267-0.317)
0.492
ENOSF1/
TYMS
rs16430 +(-) 0.297
(0.292-0.302)
0.301
(0.284-0.318)
0.273
(0.251-0.295)
0.300
(0.293-0.307)
0.305
(0.280-0.330)
0.314
FUT2 rs601338 G(A) 0.456
(0.451-0.461)
0.486
(0.468-0.504)
0.394
(0.370-0.418)
0.452
(0.444-0.460)
0.502
(0.475-0.529)
<0.0001
LDLR rs688 C(T) 0.423
(0.418-0.428)
0.443
(0.425-0.461)
0.406
(0.382-0.430)
0.421
(0.414-0.428)
0.420
(0.393-0.447)
0.038
GNAS rs7121 C(T) 0.477
(0.472-0.482)
0.500
(0.482-0.518)
0.468
(0.443-0.493)
0.475
(0.467-0.483)
0.473
(0.446-0.500)
0.317
CBS rs234706 G(A) 0.348
(0.343-0.353)
0.342
(0.325-0.359)
0.331
(0.308-0.354)
0.347
(0.340-0.354)
0.344
(0.318-0.370)
0.266
IL1B rs16944 G(A) 0.329
(0.324-0.334)
0.343
(0.326-0.360)
0.326
(0.303-0.349)
0.332
(0.325-0.339)
0.312
(0.287-0.337)
0.170
Table 3: Population Caucasian allele frequencies stratified by self reported region of ancestry (Continued)C
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NOS3 rs1799983 G(T) 0.308
(0.303-0.313)
0.318
(0.301-0.335)
0.287
(0.265-0.309)
0.309
(0.302-0.316)
0.296
(0.271-0.321)
0.420
TGFB1 rs1800469 C(T) 0.306
(0.301-0.311)
0.299
(0.282-0.316)
0.320
(0.297-0.343)
0.309
(0.302-0.316)
0.296
(0.271-0.321)
0.742
TNFa rs1800629 G(A) 0.171
(0.167-0.175)
0.189
(0.175-0.203)
0.156
(0.138-0.174)
0.169
(0.163-0.175)
0.172
(0.152-0.192)
0.009
IL6 rs1800795 G(C) 0.440
(0.435-0.445)
0.430
(0.412-0.448)
0.453
(0.428-0.478)
0.438
(0.430-0.446)
0.455
(0.428-0.482)
0.200
IL6 rs1800796 G(C) 0.052
(0.050-0.054)
0.055
(0.047-0.063)
0.063
(0.051-0.075)
0.051
(0.048-0.054)
0.045
(0.034-0.056)
0.108
IL10 rs1800872 C(A) 0.240
(0.236-0.244)
0.236
(0.220-0.252)
0.242
(0.221-0.263)
0.240
(0.234-0.246)
0.244
(0.221-0.267)
0.551
MTHFR rs1801133 C(T) 0.327
(0.322-0.332)
0.322
(0.305-0.339)
0.307
(0.284-0.330)
0.327
(0.320-0.334)
0.325
(0.300-0.350)
0.677
LPL rs268 A(G) 0.020
(0.019-0.021)
0.020
(0.015-0.025)
0.017
(0.011-0.023)
0.021
(0.019-0.023)
0.032
(0.022-0.042)
0.034
ACE rs4291 A(T) 0.377
(0.372-0.382)
0.377
(0.359-0.395)
0.373
(0.349-0.397)
0.379
(0.372-0.386)
0.379
(0.353-0.405)
0.879
ACE rs4343 G(A) 0.479
(0.474-0.484)
0.480
(0.462-0.498)
0.506
(0.481-0.531)
0.476
(0.468-0.484)
0.488
(0.461-0.515)
0.009
APOE rs429358 T(C) 0.145
(0.141-0.149)
0.151
(0.138-0.164)
0.117
(0.101-0.133)
0.138
(0.133-0.143)
0.182
(0.161-0.203)
<0.0001
APOE rs7412 C(T) 0.083
(0.080-0.086)
0.077
(0.067-0.087)
0.082
(0.068-0.096)
0.089
(0.085-0.093)
0.076
(0.062-0.090)
0.299
COMT rs4680 A(G) 0.466
(0.461-0.471)
0.470
(0.452-0.488)
0.484
(0.459-0.509)
0.467
(0.459-0.475)
0.421
(0.394-0.448)
0.009
VDR rs7975232 A(C) 0.483
(0.478-0.488)
0.481
(0.463-0.499)
0.491
(0.466-0.516)
0.488
(0.480-0.496)
0.468
(0.441-0.495)
0.113
VDR rs731236 T(C) 0.387
(0.382-0.392)
0.380
(0.362-0.398)
0.365
(0.341-0.389)
0.382
(0.375-0.389)
0.384
(0.358-0.410)
0.284
VDR rs1544410 G(A) 0.392
(0.387-0.397)
0.387
(0.369-0.405)
0.368
(0.344-0.392)
0.387
(0.380-0.394)
0.387
(0.361-0.413)
0.479
Table 3: Population Caucasian allele frequencies stratified by self reported region of ancestry (Continued)Cross et al. BMC Genetics 2010, 11:51
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the racial categories (50 African Americans) and several
alleles have zero in at least one homozygote category.
Racial ca tegory was se lf report ed by an individual and
admixtures were not determined, a single racial group
was chosen by the individual.
As expected, our minority population allele frequencies
were significantly different from the Caucasian allele fre-
quencies for the majority (79%) of the tested polymor-
phisms, with 25% of the tested polymorphisms switching
major and minor alleles between races. These differences
will need to be considered when determining TAG and
causal variants for disease. As an example, one of the IL6
polymorphisms tested here, rs1800796, has had both the
C and G allele associated with osteoporosis depending on
the race of the individual [28,29]. In Asians and Cauca-
sians the minor allele is reversed creating complexity for
determining the causal variant [30,31]. The IL1 B poly-
morphism (rs16944) exhibits different allele frequencies
between races as well and the same allele has been shown
in meta-analysis to be protective for gastric cancer in
Asians and a risk factor for Caucasians [32-34]. Wide dif-
ferences in allele frequencies may also contribute to dif-
ferences in disease prevalence between racial groups. For
instance the cystic fibrosis has large racial disparities [35]
and as expected we found large differences in the CFTR
gene (rs213950) among different racial groups in our
population.
Here, we also began to investigate further substructure
of our population within a single racial category. Because
of the low number of minority racial groups in our popu-
lation we chose to investigate potential substructure
within only our Caucasian population. Using self
reported region of ancestry, we found that 37% of the
tested polymorphisms were significantly different
between individuals reporting different regions of ances-
try. Recent substructure analysis of Icelandic [23], Swed-
ish[24,36], and Ashkenazi Jewish populations [22,37]
determined that substructure was present even in these
seemingly homogenous populations and that the sub-
structure has implications for disease risk [2-5,22-24,36].
This study is one of the largest US studies to stratify a
population by region of origin and demonstrates the large
heterogeneity of the population even within a single
racial group. These differences in allele frequencies may
Figure 3 Minor allele frequencies that vary significantly by region of origin. Minor allele frequency for the Caucasian population and the same 
allele for each region of origin, with 95% confidence intervals.
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need to be considered when designing association studies
in the future. One weakness of our analysis is the inability
to categorize almost half (43%) of our Caucasian popula-
tion into a single region of origin, because of our inability
to determine the admixture given the self reported nature
of the questionnaire and our limited genotyping. We are
currently examining the more than 4000 individuals with
whole genome scans completed to determine the ethnici-
ties and regions of origin with greater accuracy.
Stratification of the population by sex revealed few dif-
ferences in allele frequency within our population. This is
similar to previously reported sex stratifications of large
populations. The three genes that exhibited sex differ-
ences in our population (GNAS, ADRB1 and ADRB2)
have also demonstrated gene-gender interactions in other
studies. Interestingly, ADRB1 and ADRB2 alleles are
associated with differential gender responses in blood
pressure [38], and in rats these genes interact with sex
hormones in a differential manner [39]. The GNAS gene
was associated with different responses to hip arthro-
plasty [40]. While allele frequency differences between
the sexes may not be frequent when they occur this may
be an indicator of potential gene-gender interactions for
future research.
Conclusions
Using a panel of polymorphisms originally designed to
uniquely identify individuals within our biorepository we
were able to construct population allele frequencies for
the PMRP population. In doing so, we have highlighted
the need to consider population substructure beyond
race using a large Caucasian population. Stratification of
the population may lead to increased study power for
future association studies. The genotyping data is avail-
able to investigators using the PMRP resource both for
identification purposes and as a resource for investigating
gene disease interactions.
Methods
Study population and questionnaire
The Personalized Medicine Research Project is a popula-
tion based cohort of approximately 20,000 individuals
ages 18 and up residing within one of 19 zip codes sur-
rounding Marshfield Wisconsin, USA, who have agreed
to provide DNA, serum, and plasma samples to be linked
with a dynamic medical record for research [26]. Individ-
uals are eligible to participate in the project if they have
had care within the Marshfield Clinic Healthcare System
within the 3 years prior to enrolment in PMRP. The
majority of recruitment was accomplished in the first 18
months of enrolment beginning in September of 2002. At
enrolment each individual was asked to complete a brief
questionnaire which included questions regarding self
r e p o r t e d  r a c i a l  a f f i l i a t i o n s  a n d  s e l f  r e p o r t e d  a n c e s t r y
using the US census questions, as well as occupational
and environmental exposure questions. The enrolment
questionnaire is available on the PMRP website [41] and
the resulting summary statistics for our population has
been published elsewhere [26].
The racial, ethnic and sex distribution of this cohort
has been described previously. Briefly, the current cohort
is over 98% Caucasian and 57.44% are females, with a
mean age of 47.5 at enrolment [26]. For this study, 19544
individuals who self reported a single racial category were
examined to determine allele frequencies. Individuals
were allowed to select more than one ancestral origin. For
this study individuals were grouped into four regions of
ancestral origins: England or Ireland, Norway or Sweden,
Czech Republic or Poland, and Germany. Individuals who
selected two disparate regions were excluded from our
ancestral analysis due to our inability to determine
admixture percentages. However, individuals who
selected multiple countries of origin within the same
region were included in the analysis. (As an example, an
individual selecting ancestral origin from both Norway
and Sweden would be used in the analysis but an individ-
ual selecting Ireland and Germany would be excluded).
Informed consent was obtained upon enrolment in
P M RP  a n d  t h is  s t u d y  was  a p p r o v ed  b y  t h e  M a r s h fi e l d
Clinic Human Subjects Protection Institutional Review
Board.
Genotyping
The entire population was genotyped with 2 multiplex
panels for a total of 52 alleles, including a sex marker,
using the proprietary Sequenom® platform (Additional
File 1). An initial panel of 36 alleles was genotyped to
serve as a quality control and assurance panel. Each allele
in the panel was previously associated with at least one
disease and was reported to have at least a 20% minor
allele frequency in Caucasians[27]. In addition, a separate
panel of 15 alleles each with at least one association with
disease in Caucasian populations and with no restriction
on allele frequency was also genotyped in the entire
cohort. Only individuals who achieved an 80% or greater
call rate were used in the study. In addition, each poly-
morphism was required to achieve at least an 80% call
rate. Individual genotypes were decided via a mixture of
automated calls from Typer 3.4 ® [42] and manual calls;
manual calls were checked by multiple individuals to
assure agreement with the genotype assessment. Each
multiplexed plate contained 4 water controls and 6 CEPH
controls with 2 duplicate samples to ensure plate to plate
accuracy. 8 individuals were duplicated blindly within the
genotyping plates and all previous allele calls were com-
pared to the study allele calls to ensure consistency within
the cohort. In addition over 4,000 individuals in the
cohort have been independently assayed using the Illu-Cross et al. BMC Genetics 2010, 11:51
http://www.biomedcentral.com/1471-2156/11/51
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mina 660 whole genome chip [43]. Discrepancies
between genotyping were resolved with sequencing.
Statistical Analysis
Hardy-Weinberg equilibrium was determined and poly-
morphisms were said to be out of equilibrium if the
expected and observed allele frequency were outside of
the 99% Confidence interval 1 degree of freedom using a
χ2 test. Allele frequencies were compared to reported
allele frequencies both as a summary and for self reported
racial group. Differences in allele frequencies between
self reported racial, ethnic groups were determined using
chi-squared analysis and the 95% binomial confidence
limits were reported. Differences between the sexes were
determined using chi-squared analysis. Differences were
reported as significant if P < 0.05.
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